Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Tommaso who wrote (117286)	12/16/2008 7:20:13 PM
From: starhawke	Read Replies (1) \| Respond to of 132070

Shhhhhh. Don't give him any ideas. <g>

To: Tommaso who wrote (117286)	12/17/2008 10:15:10 AM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

And worth every penny. <G>

To: Tommaso who wrote (117286)	12/17/2008 10:30:38 AM
From: hdl	Read Replies (1) \| Respond to of 132070

i would sue him re tbt, but everyone is busy suing re madoff.

To: Tommaso who wrote (117286)	12/17/2008 12:34:00 PM
From: Knighty Tin	Read Replies (2) \| Respond to of 132070

I'm trying to get a handle on Lilly. The 5.3% dividend is safe from a cash flow perspective, but not from eps, as it is 90% of eps. The drug pipeline looks solid right now. The stock is not as close to its yearly low as I'd prefer and I'd like the pe ratio to decline a bit, but a very intriguing, high yield stock with growth potential. PFE is my first choice for this sort of speculation, but LLY is another one that offers some riskier but possibly more profitable returns than "safe choice" JNJ. And I think LLY's pipeline is more exciting than PFE's.